company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,15866000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,21513000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,618000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,420000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,38417000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1183000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,855000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,61000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2686000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3602000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,,totalassets,Total Assets,=,debit,usd,43202000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,9171000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9337000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,232000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,901000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,271000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19912000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,19926000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,407000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,276000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2407000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,23016000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,42928000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,49000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,49464000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-49247000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,8000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,225000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,274000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,274000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q1,,2012-03-31,2012-06-08 16:47:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,43202000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,47242000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,29150000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1010000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,403000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,77805000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1146000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,798000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,55000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,161000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1014000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,,totalassets,Total Assets,=,debit,usd,79965000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,10747000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9175000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,365000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1335000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,259000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21881000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,17061000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,183000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,259000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2601000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,20104000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,41985000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,97233000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-59259000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,6000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,37980000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,37980000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,37980000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q2,,2012-06-30,2012-08-13 16:52:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,79965000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,23412000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,275000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,37256000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,500000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,26000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1276000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,144000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,62889000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1384000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1804000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,740000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,55000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,142000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2741000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,,totalassets,Total Assets,=,debit,usd,67014000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,11490000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10485000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,576000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1801000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,238000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,24590000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,14116000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,381000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,275000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3021000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,17793000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,42383000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,97402000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-72742000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-29000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,24631000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,24631000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,24631000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2012.0,Q3,,2012-09-30,2012-11-02 17:07:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,67014000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,18909000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,50983000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,672000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1650000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,3113000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,861000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,144000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcurrentassets,othercurrentnonoperatingassets,Other Current Nonoperating Assets,+,debit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,76332000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1687000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,626000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,363000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,53000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1042000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,,totalassets,Total Assets,=,debit,usd,79061000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,12137000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10903000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3968000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,27008000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,7975000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,774000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2032000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10781000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,37789000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,146030000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-104669000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-89000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,41272000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,41272000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,41272000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q1,,2013-03-31,2013-05-15 16:17:38+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,79061000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33907000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,68725000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,791000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,537000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,4315000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1912000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,430000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,110617000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2247000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,16072000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,568000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,360000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2109000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,19109000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,,totalassets,Total Assets,=,debit,usd,131973000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11732000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4292000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16024000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,59100000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,738000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,20219000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,80057000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,96081000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,168153000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-132026000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-235000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,35892000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,35892000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,35892000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q2,,2013-06-30,2013-08-14 07:03:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,131973000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,22945000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,64293000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,982000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,7208000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,5188000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1815000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,431000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,102862000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2480000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,15215000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,817000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,360000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,2031000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,18423000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,,totalassets,Total Assets,=,debit,usd,123765000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,14472000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10599000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,25071000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,60175000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1452000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,24614000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,86241000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,111312000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,168656000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-156122000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-81000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,12453000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,12453000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,12453000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2013.0,Q3,,2013-09-30,2013-11-12 18:10:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,123765000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12252000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,46615000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,636000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9725000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,7957000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2559000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,185000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcurrentassets,othercurrentnonoperatingassets,Other Current Nonoperating Assets,+,debit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,79929000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2648000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,11662000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2157000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,360000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,764000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,14943000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,,totalassets,Total Assets,=,debit,usd,97520000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,14658000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,12444000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcurrentliabilities,othercurrentnonoperatingliabilities,Other Current Nonoperating Liabilities,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,27102000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,28358000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1381000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalnoncurrentliabilities,noncurrentemployeebenefitliabilities,Noncurrent Employee Benefit Liabilities,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,11666000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalnoncurrentliabilities,othernoncurrentnonoperatingliabilities,Other Noncurrent Nonoperating Liabilities,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,41405000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,68507000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,223083000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-194071000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,29013000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,29013000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,29013000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q1,,2014-03-31,2014-05-13 16:16:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,97520000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,11956000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,35314000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,496000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,10854000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,10101000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3058000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,202000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,71981000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2590000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,15462000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3083000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,361000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,713000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,19619000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,,totalassets,Total Assets,=,debit,usd,94190000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,19044000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,143000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,19187000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,28671000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1345000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,11618000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,41634000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,60821000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,224238000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-190870000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,33369000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,33369000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,33369000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q2,,2014-06-30,2014-08-12 16:16:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,94190000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,37780000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,34783000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,15303000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,11145000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3791000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,102802000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2500000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,15763000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,4135000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,360000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,20258000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,,totalassets,Total Assets,=,debit,usd,125560000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1573000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,20410000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,143000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22126000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,25732000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1310000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,40400000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,67442000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,89568000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,229268000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-193241000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-35000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,35992000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,35992000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,35992000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2014.0,Q3,,2014-09-30,2017-01-20 17:26:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,125560000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,25158000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,39678000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,19271000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,13702000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3640000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,101449000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2481000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,27315000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,167000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,7993000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,35475000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,,totalassets,Total Assets,=,debit,usd,139405000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,859000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,26507000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,143000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,27509000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,11476000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1238000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,35431000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,48145000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,75654000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,252531000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-188715000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-65000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,63751000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,63751000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,63751000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q1,,2015-03-31,2017-01-20 17:28:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,139405000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,32457000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,37334000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,17900000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,13592000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4417000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,105700000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2908000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,33488000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,110000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11808000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,45406000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,,totalassets,Total Assets,=,debit,usd,154014000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4518000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,31970000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,143000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36631000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,8608000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1202000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,35751000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,45561000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,82192000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,258250000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-186277000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-151000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,71822000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,71822000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,71822000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q2,,2015-06-30,2017-01-20 18:14:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,154014000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,25641000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,32061000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,23603000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,14742000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6468000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,102515000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3210000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,43967000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,16627000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,322000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,60916000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,,totalassets,Total Assets,=,debit,usd,166641000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2812000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,40474000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,143000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,261000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,43690000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,7939000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1167000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,35258000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,44364000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,88054000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,261055000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-182361000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-107000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,78587000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,78587000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,78587000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2015.0,Q3,,2015-09-30,2017-01-20 17:26:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,166641000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,19830000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,25427000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,30651000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,13044000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5003000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,93955000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3866000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,68790000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,16108000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11755000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,96653000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,,totalassets,Total Assets,=,debit,usd,194474000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2646000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,51612000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,208000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1067000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,55533000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,5627000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1658000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,34547000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,41832000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,97365000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,267625000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-170684000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,168000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,97109000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,97109000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,97109000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q1,,2016-03-31,2017-01-20 17:28:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,194474000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,36156000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,24058000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,34281000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,16373000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3272000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,114140000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4193000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,67809000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,15785000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,16706000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,100300000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,,totalassets,Total Assets,=,debit,usd,218633000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2243000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,63154000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,208000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1909000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,67514000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,5699000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1606000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,33589000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,40894000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,108408000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,270109000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-160433000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,549000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,110225000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,110225000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,110225000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q2,,2016-06-30,2017-01-20 18:14:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,218633000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,54305000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,26024000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,36220000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,17453000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4201000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,138203000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4318000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,67044000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,15526000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,42256000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,17769000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,142595000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,,totalassets,Total Assets,=,debit,usd,285116000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2685000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,66413000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,207000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2342000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,71647000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,5772000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1554000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,32772000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,40098000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,111745000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,271851000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-98607000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,127000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,173371000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,173371000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,173371000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2016.0,Q3,,2016-09-30,2017-01-20 17:31:43+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,285116000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,59599000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,27533000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,38885000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,19167000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4573000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,149757000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4342000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,89163000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,29450000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,37863000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11681000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,168157000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,,totalassets,Total Assets,=,debit,usd,322256000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5056000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,70340000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,287000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1675000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,4645000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,82003000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,3310000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1365000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,29514000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,34189000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,116192000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,279842000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-73810000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,32000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,206064000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,206064000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,206064000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q1,,2017-03-31,2017-05-09 17:18:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,322256000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61737000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,31229000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,51157000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,16623000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4746000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,165492000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4572000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,104632000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,28989000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,30449000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,12236000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,176306000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,,totalassets,Total Assets,=,debit,usd,346370000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7577000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,71055000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,287000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,1608000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,4997000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,85524000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,1472000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1293000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,28684000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,31449000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,116973000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,285623000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-56442000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,216000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,229397000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,229397000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,229397000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q2,,2017-06-30,2017-08-03 15:48:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,346370000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,81924000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,32626000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,56166000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,14947000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5667000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,191330000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4688000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,123123000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,37162000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,28807000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,368000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,189460000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,,totalassets,Total Assets,=,debit,usd,385478000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6262000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,86664000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,287000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,6489000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,5254000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,104956000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1221000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,27638000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,28859000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,133815000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,291892000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-40481000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,252000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,251663000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,251663000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,251663000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2017.0,Q3,,2017-09-30,2017-11-08 17:39:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,385478000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,444140000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,45585000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,67864000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,19075000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6582000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,583246000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5003000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,175064000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,34858000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,26254000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,735000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,236911000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,,totalassets,Total Assets,=,debit,usd,825160000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3333000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,98058000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,16265000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1432000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,119088000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,318225000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,35978000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,354203000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,473291000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,352309000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,1851000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2291000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,351869000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,351869000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,351869000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q1,,2018-03-31,2018-05-10 13:57:37+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,825160000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,35205000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,139208000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,74842000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,20680000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,14581000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,284516000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4897000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,503312000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,33794000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,25528000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,752000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,563386000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,,totalassets,Total Assets,=,debit,usd,852799000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2943000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,99332000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1659000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,103934000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,321920000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,36453000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,358373000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,462307000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,362023000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,32588000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-4119000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,390492000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,390492000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,390492000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q2,,2018-06-30,2018-08-09 15:17:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,852799000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,123818000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,156407000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,77753000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,23280000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9299000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,390557000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6930000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,460304000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,32572000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,31367000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,782000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,525025000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,,totalassets,Total Assets,=,debit,usd,922512000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9838000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,118068000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,8548000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1892000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,138346000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,325666000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,36564000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,362230000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,500576000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,365448000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,60599000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-4111000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,421936000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,421936000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,421936000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2018.0,Q3,,2018-09-30,2018-11-09 09:49:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,922512000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,122778000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,170165000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,79950000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,26518000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,20556000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,419967000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4226000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,522551000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,30063000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,27967000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,20674000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,601255000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,,totalassets,Total Assets,=,debit,usd,1025448000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,43847000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,88200000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,17233000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2426000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,151706000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,333310000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,60414000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,393724000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,545430000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,373759000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,104832000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1427000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,480018000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,480018000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,480018000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q1,,2019-03-31,2019-05-10 15:38:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1025448000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,87344000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,171222000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,84564000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,26024000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,21757000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,390911000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4028000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,593754000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,28787000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,25975000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,20220000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,668736000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,,totalassets,Total Assets,=,debit,usd,1063675000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,42695000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,95934000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,2674000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2668000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,143971000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,337210000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,59590000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,396800000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,540771000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,379421000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,137559000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,5924000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,522904000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,522904000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,522904000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q2,,2019-06-30,2019-08-09 11:02:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1063675000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,116889000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,179808000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,86699000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,25504000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,18182000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,427082000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9977000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,596442000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,26101000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,27953000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,19354000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,669850000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,,totalassets,Total Assets,=,debit,usd,1106909000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,43890000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,98050000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,4818000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2959000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,149717000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,341163000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,58772000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,399935000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,549652000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,383577000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,166419000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,7261000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,557257000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,557257000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,557257000.0
Supernus Pharmaceuticals Inc,SUPN,,0001356576,2019.0,Q3,,2019-09-30,2019-11-08 14:59:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1106909000.0
